Consonance Capital Management LP / HRTX
Consonance Capital Management LP’s Heron Therapeutics Inc Position
Does Consonance Capital Management LP own Heron Therapeutics Inc (HRTX)? Not currently — the last reported position was 2.01M shares worth $30M in Q3 2020; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$30M
Q3 2020
Shares
2.01M
% of Portfolio
+3.62%
Quarters Held
1
position exited
Position History HRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2020 | 2.01M | $30M | +3.62% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of HRTX.